摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-疏基喹啉 | 51812-96-5

中文名称
4-疏基喹啉
中文别名
——
英文名称
4-mercaptoquinoline
英文别名
4-quinolinethione;quinoline-4-thiol;Chinolin-4-thiol;4-Mercaptochinolin;1H-quinoline-4-thione
4-疏基喹啉化学式
CAS
51812-96-5
化学式
C9H7NS
mdl
MFCD00956872
分子量
161.227
InChiKey
ROYCCMJSURLMLI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    159-163 °C
  • 密度:
    1.246±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    44.1
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933499090
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P302+P352,P304+P340,P305+P351+P338,P312,P330,P362,P403+P233,P501
  • 危险性描述:
    H302,H312,H332
  • 储存条件:
    2-8°C

SDS

SDS:c20bc307143269a71955d3ae02f12a02
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    FRANCISCO, MANUEL A.;KURS, ARGO;KATRITZKY, ALAN R.;RASALA, DANUTA, J. ORG. CHEM., 53,(1988) N 20, C. 4821-4826
    摘要:
    DOI:
  • 作为产物:
    描述:
    4-氯喹啉mesna 作用下, 生成 4-疏基喹啉
    参考文献:
    名称:
    由未活化的芳基卤化物方便地合成芳族硫醇
    摘要:
    从未活化的芳基卤化物和HMPA中过量的MeSNa可获得高收率的芳族硫醇。
    DOI:
    10.1016/s0040-4039(00)77418-1
点击查看最新优质反应信息

文献信息

  • PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
    申请人:SHANGHAI BLUERAY BIOPHARMA CO., LTD.
    公开号:US20210053989A1
    公开(公告)日:2021-02-25
    Disclosed in the present disclosure are a pyrimidine-fused cyclic compound or a pharmaceutically acceptable salt, hydrate, prodrug, stereoisomer, solvate or isotope labeled compound thereof. Also provided in the present disclosure are a preparation method for the compound, a composition comprising the compound and a use of the compound for the preparation of a medicament for the prevention and/or treatment of a disease or condition associated with abnormal SHP2 activity.
    本公开涉及一种嘧啶融合的环状化合物或其药用可接受的盐、水合物、前药、立体异构体、溶剂合物或同位素标记化合物。本公开还提供了该化合物的制备方法、包含该化合物的组合物以及该化合物用于制备与异常SHP2活性相关的疾病或病况的药物的用途。
  • Heterocyclic Amplifiers of Phleomycin. IX. Some Derivatives of Fused and Unfused Mono- and Di-aza Heterocycles
    作者:GB Barlin、SJ Ireland
    DOI:10.1071/ch9851685
    日期:——

    Some mono- and bis-dimethylaminoethylthio, dimethylaminopropylthio and carbamoylmethylthio derivatives of pyridine, pyridazine , 1,3,4- thiadiazole , thiazoline , quinoline , quinoxaline , quinazoline , phthalazine , 6-nitrobenzothiazole and benzimidazo [1,2-c] quinazoline have been prepared for testing as amplifiers of phleomycin. These compounds showed relatively low activity; the highest activity was shown by 4-(2′-dimethylaminoethylthio) quinoline at three star, but a number were antibacterial under the test conditions.

    制备了吡啶、哒嗪、1,3,4-噻二唑、噻唑啉、喹啉、喹喔啉、喹唑啉、酞嗪、6-硝基苯并噻唑和苯并咪唑并[1,2-c]喹唑啉的一些单二甲胺基乙硫基、二甲胺基丙硫基和氨基甲酰甲硫基衍生物,并将其作为弗来霉素的放大剂进行试验。这些化合物的活性相对较低;4-(2′-二甲氨基乙硫基)喹啉的活性最高,为 3 星,但在试验条件下,一些化合物具有抗菌作用。
  • OPTICAL RECORDING MEDIUM AND AZO METAL CHELATE COMPOUND
    申请人:Mitsui Chemicals, Inc.
    公开号:EP1997856A1
    公开(公告)日:2008-12-03
    The present invention is to provide an optical recording medium which is capable of performing good recording and reproducing by using a laser having a wavelength of 300 to 900 nm, a novel azo metal chelate compound, and a novel azo compound. Furthermore, the present invention is to provide an optical recording medium having an azo metal chelate compound in a recording layer.
    本发明提供了一种光记录介质,通过使用波长为300至900纳米的激光、一种新型偶氮金属螯合物和一种新型偶氮化合物,能够进行良好的记录和再现。此外,本发明提供了一种在记录层中含有偶氮金属螯合物的光记录介质。
  • Penem derivatives and antimicrobial agents containing the same
    申请人:SUNTORY LIMITED
    公开号:EP0774465A1
    公开(公告)日:1997-05-21
    Penem derivatives represented by the following Formula (I): wherein Z represents a hydroxyl group or a fluorine atom, R1 represents a substituted or unsubstituted alkyl, alkenyl, aralkyl group, aryl group, heterocyclic, or acyl group, or a hydrogen atom, and R2 represents a hydrogen atom or a carboxyl-protecting group; and pharmacologically acceptable salts thereof are antibacterial agents effective against, inter alia, methicillin-resistant Staphylococcus aureus. The derivatives and salts are novel except when R1 is ethyl and Z is hydroxyl. The analogous compounds in which R2 is a carboxyl-protecting group and any hydroxyl group represented by Z is protected are novel process intermediates.
    Penem衍生物由以下公式(I)表示:其中Z代表一个羟基团或氟原子,R1代表一个取代或未取代的烷基,烯基,芳基甲基,芳基,杂环基或酰基,或氢原子,R2代表一个氢原子或羧基保护基;及其药理学上可接受的盐是有效的抗菌剂,可用于治疗耐甲氧西林金黄色葡萄球菌等感染。这些衍生物和盐是新颖的,除非R1是乙基且Z是羟基。其中R2是羧基保护基且Z代表的任何羟基被保护的类似化合物是新颖的工艺中间体。
  • Amide derivatives
    申请人:Muto Susumu
    公开号:US20050215645A1
    公开(公告)日:2005-09-29
    A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the following general formula (I) or a salt thereof: wherein one of R 1 and R 2 represents hydrogen atom and the other represents the formula —X-A wherein A represents hydrogen atom or an acyl group, X represents oxgen atom or NH; one of R 3 and R 4 represents hydrogen atom and the other represents the following formula: wherein Y represents a sulfonyl group or a carbonyl group, R 5 represents a cyclic group, Z represents a single bond or a C 1 to C 4 alkylene group, R 6 represents hydrogen atom or a C 1 to C 6 alkyl group.
    一种用于增强基于DNA损伤作用的癌症治疗效果的药物,其活性成分为以下一般式(I)或其盐表示的化合物:其中R1和R2中的一个代表氢原子,另一个代表式—X-A,其中A代表氢原子或酰基,X代表氧原子或NH;R3和R4中的一个代表氢原子,另一个代表以下式:其中Y代表磺酰基或羰基,R5代表环状基团,Z代表单键或C1到C4烷基烷基,R6代表氢原子或C1到C6烷基基团。
查看更多